India to United States: Sorafenib Export Trade Route
India has recorded 24 verified shipments of Sorafenib exported to United States, representing a combined trade value of $12.5M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $520.1K USD. The leading Indian exporter is DR REDDY S LABORATORIES LIMITED, which accounts for 36% of total export value with 1 shipments worth $4.5M USD. On the buying side, XX RXXDY XXLABXXATOXXES XXC is the largest importer in United States with $4.5M USD in purchases. The top 3 suppliers — DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, TORRENT PHARMACEUTICALS LTD — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Sorafenib corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $12.5M USD. The route is dominated by DR REDDY S LABORATORIES LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's sorafenib manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $520.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with sorafenib's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 30.7%, placing it at rank #8 among India's top sorafenib export destinations globally.
On the import side, key buyers of Indian sorafenib in United States include XX RXXDY XXLABXXATOXXES XXC, DR REDDY S LABORATORIES INC, TORRENT PHARMA INC and 8 others. XX RXXDY XXLABXXATOXXES XXC is the single largest importer with 1 shipments valued at $4.5M USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#8
- Annual growth+30.7%
- Demand growth+25.7%
- Regulatory ease71/100
Top 10 Indian Sorafenib Exporters to United States
Showing top 10 of 7 Indian suppliers exporting Sorafenib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR REDDY S LABORATORIES LIMITED Avg $4.5M per shipment | 1 | $4.5M | 36.2% |
| 2 | DR REDDYS LABORATORIES LIMITED Avg $4.5M per shipment | 1 | $4.5M | 36.2% |
| 3 | TORRENT PHARMACEUTICALS LTD Avg $288.7K per shipment | 11 | $3.2M | 25.4% |
| 4 | TORRENT PHARMACEUTICALS LIMITED Avg $259.2K per shipment | 1 | $259.2K | 2.1% |
| 5 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $820 per shipment | 8 | $6.6K | 0.1% |
| 6 | KOIT BIOPHARMA PRIVATE LIMITED Avg $524 per shipment | 1 | $524 | 0.0% |
| 7 | MERIT POLYCHEM PVT. LTD. Avg $88 per shipment | 1 | $88 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting sorafenib to United States, ranked by total trade value. The listed exporters are: DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, KOIT BIOPHARMA PRIVATE LIMITED, MERIT POLYCHEM PVT. LTD.. DR REDDY S LABORATORIES LIMITED is the dominant supplier with 1 shipments worth $4.5M USD, giving it a 36% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Sorafenib Importers in United States
Showing top 10 of 11 known buyers in United States receiving Sorafenib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sorafenib in United States include XX RXXDY XXLABXXATOXXES XXC, DR REDDY S LABORATORIES INC, TORRENT PHARMA INC, TORRENT PHARMA INC,, VERONICA HERNANDEZ HDZ, among 11 total buyers. The largest importer is XX RXXDY XXLABXXATOXXES XXC, accounting for $4.5M USD across 1 shipments — representing 36% of all sorafenib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | XX RXXDY XXLABXXATOXXES XXC | 1 | $4.5M | 36.2% |
| 2 | DR REDDY S LABORATORIES INC | 1 | $4.5M | 36.2% |
| 3 | TORRENT PHARMA INC | 8 | $2.0M | 16.0% |
| 4 | TORRENT PHARMA INC, | 4 | $1.4M | 11.5% |
| 5 | VERONICA HERNANDEZ HDZ | 4 | $3.0K | 0.0% |
| 6 | CONCEPCION GORDILLO MENDEZ | 1 | $1.8K | 0.0% |
| 7 | Luis Mendez Julio Magallon | 1 | $882 | 0.0% |
| 8 | JULIO MAGALLON GARCIA BRICER | 1 | $595 | 0.0% |
| 9 | COMERCIALIZADORA MEDENOR SA DE CV | 1 | $524 | 0.0% |
| 10 | S LOG SA DE CV | 1 | $325 | 0.0% |
Showing top 10 of 11 Sorafenib importers in United States on this route.
Top 10 Sorafenib Formulations Imported by United States
Showing top 10 of 14 product formulations shipped on the India to United States Sorafenib route, ranked by trade value
United States imports a wide range of sorafenib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SORAFENIB TABLETS 200MG 120S HDPE US — accounts for $9.0M USD across 2 shipments. There are 14 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SORAFENIB TABLETS 200MG 120S HDPE US | 2 | $9.0M | 72.4% |
| 2 | SORAFENIB TABLETS USP 200MG 120S HDPE US(NDC 13668-682-12)(SORAFENIB 200MG) NOSSIZE 120'S TABLETS /BOTTLE | 4 | $1.0M | 8.3% |
| 3 | SORAFENIB TABLETS USP 200MG, 120S HDPE, US (NDC 13668-682-12)(SORAFENIB 200MG)(NOS=120'S TAB/BOTTLE)) | 3 | $1.0M | 8.1% |
| 4 | SORAFENIB TABLETS USP 200MG 120S HDPE US NDC 13668 682 12 SORAFENIB 200MG NOSSIZE 120 S TABLETS BOTTLE | 2 | $506.5K | 4.1% |
| 5 | SORAFENIB TABLETS USP 200MG 120S HDPE US | 1 | $417.9K | 3.3% |
| 6 | SORAFENIB TABLETS USP 200MG 120S HDPE USNDC 13668-682-12 NOS X 120S TAB/BOTTLE | 1 | $259.2K | 2.1% |
| 7 | SORAFENIB TABLETS USP 200MG 120S HDPE USNDC 13668-682-12 SORAFENIB 200MG NOS = 120S TAB/BOTTLE | 1 | $205.6K | 1.6% |
| 8 | Soranib 200 mg Sorafenib Inj. | 4 | $3.0K | 0.0% |
| 9 | SORANIB 200 MG ( SORAFENIB) TABNOS | 1 | $1.8K | 0.0% |
| 10 | Soranib 200 mg Sorafenib Tab | 1 | $882 | 0.0% |
Showing top 10 of 14 Sorafenib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 8 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's sorafenib exports to United States are driven primarily by a handful of large-scale manufacturers. DR REDDY S LABORATORIES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, TORRENT PHARMACEUTICALS LTD — together account for 98% of total trade value on this route. The average shipment value of $520.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as sorafenib tablets usp 200mg 120s hdpe us(ndc 13668-682-12)(sorafenib 200mg) nossize 120's tablets /bottle and sorafenib tablets usp 200mg, 120s hdpe, us (ndc 13668-682-12)(sorafenib 200mg)(nos=120's tab/bottle)), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, XX RXXDY XXLABXXATOXXES XXC is the largest importer with 1 shipments worth $4.5M USD — representing 36% of all sorafenib imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $12.5M
- Avg. Shipment
- $520.1K
- Suppliers
- 7
- Buyers
- 11
- Transit (Sea)
- ~33 days
- Annual Growth
- +30.7%
Other Sorafenib Routes
Unlock the Full India to United States Sorafenib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 24 shipments on this route.
Frequently Asked Questions — India to United States Sorafenib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sorafenib to United States?
The leading Indian exporters of Sorafenib to United States are DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, TORRENT PHARMACEUTICALS LTD. DR REDDY S LABORATORIES LIMITED holds the largest market share at approximately 36% of total trade value on this route.
Q What is the total value of Sorafenib exports from India to United States?
India exports Sorafenib to United States worth approximately $12.5M USD across 24 recorded shipments. The average value per shipment is $520.1K USD.
Q Which ports does India use to ship Sorafenib to United States?
The most active port of origin is SAHAR AIR with 8 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to United States for Sorafenib?
The average transit time for Sorafenib shipments from India to United States is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Sorafenib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.7% with demand growth tracking at 25.7%. The route is ranked #8 among India's top Sorafenib export destinations globally.
Q How many suppliers are active on the India to United States Sorafenib route?
There are currently 7 active Indian suppliers exporting Sorafenib to United States. The market is moderately concentrated with DR REDDY S LABORATORIES LIMITED accounting for 36% of total shipment value.
Q Who are the main importers of Sorafenib from India in United States?
The leading importers of Indian Sorafenib in United States include XX RXXDY XXLABXXATOXXES XXC, DR REDDY S LABORATORIES INC, TORRENT PHARMA INC, TORRENT PHARMA INC,, VERONICA HERNANDEZ HDZ. XX RXXDY XXLABXXATOXXES XXC is the largest buyer with 1 shipments worth $4.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Sorafenib.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 11 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 24 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
24 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists